Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain.

Segui MA, Cruz JJ, Alba E, Feliu J, Jara C, Rivera F, Rodriguez Lescure A, Lorenzo A, Martin M.

Clin Transl Oncol. 2019 Nov 8. doi: 10.1007/s12094-019-02230-8. [Epub ahead of print] Review.

PMID:
31701365
2.

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI).

Feliu J, Potter V, Grimaldi F, Clay J, Floro L, Saha C, Barber L, Orti G, Alnagar AA, Garcia-Muñoz R, Kenyon M, Krishnamurthy P, de Lavallade H, Raj K, McLornan D, Pagliuca A, Mufti GJ.

Bone Marrow Transplant. 2019 Sep 26. doi: 10.1038/s41409-019-0695-x. [Epub ahead of print]

PMID:
31558789
3.

Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.

Cardone C, Martinelli E, Troiani T, Sforza V, Avallone A, Nappi A, Montesarchio V, Andreozzi F, Biglietto M, Calabrese F, Bordonaro R, Cordio S, Bregni G, Febbraro A, Garcia-Carbonero R, Feliu J, Cervantes A, Ciardiello F.

ESMO Open. 2019 Aug 16;4(4):e000519. doi: 10.1136/esmoopen-2019-000519. eCollection 2019.

4.

Coherent Bragg imaging of 60 nm Au nanoparticles under electrochemical control at the NanoMAX beamline.

Björling A, Carbone D, Sarabia FJ, Hammarberg S, Feliu JM, Solla-Gullón J.

J Synchrotron Radiat. 2019 Sep 1;26(Pt 5):1830-1834. doi: 10.1107/S1600577519010385. Epub 2019 Aug 27.

5.

Surface Structure Characterization of Shape and Size Controlled Pd Nanoparticles by Cu UPD: A Quantitative Approach.

Garnier E, Vidal-Iglesias FJ, Feliu JM, Solla-Gullón J.

Front Chem. 2019 Jul 31;7:527. doi: 10.3389/fchem.2019.00527. eCollection 2019.

6.

Interfacial Study of Nickel-Modified Pt(111) Surfaces in Phosphate-Containing Solutions: Effect on the Hydrogen Evolution Reaction.

Sarabia FJ, Climent V, Feliu JM.

Chemphyschem. 2019 Nov 19;20(22):3056-3066. doi: 10.1002/cphc.201900543. Epub 2019 Jul 26.

PMID:
31294504
7.

Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.

Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ.

Clin Transl Oncol. 2019 Jun 25. doi: 10.1007/s12094-019-02167-y. [Epub ahead of print] Review.

PMID:
31240462
8.

Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02).

García-Albéniz X, Alonso V, Escudero P, Méndez M, Gallego J, Rodríguez JR, Salud A, Fernández-Plana J, Manzano H, Zanui M, Falcó E, Feliu J, Gil M, Fernández-Martos C, Bohn U, Alonso C, Calderero V, Rojo F, Cuatrecasas M, Maurel J.

Oncologist. 2019 Nov;24(11):e1115-e1122. doi: 10.1634/theoncologist.2018-0728. Epub 2019 Jun 24.

9.

Vibrational Properties of Pd Nanocubes.

Flor A, Feliu JM, Tsung CK, Scardi P.

Nanomaterials (Basel). 2019 Apr 12;9(4). pii: E609. doi: 10.3390/nano9040609.

10.

Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance.

D'Errico G, Alonso-Nocelo M, Vallespinos M, Hermann PC, Alcalá S, García CP, Martin-Hijano L, Valle S, Earl J, Cassiano C, Lombardia L, Feliu J, Monti MC, Seufferlein T, García-Bermejo L, Martinelli P, Carrato A, Sainz B Jr.

Oncogene. 2019 Jul;38(27):5469-5485. doi: 10.1038/s41388-019-0803-9. Epub 2019 Apr 1.

PMID:
30936462
11.

GALLIUM trial: the tortoise (rituximab) and the hare (obinutuzumab) race.

García-Muñoz R, Anton-Remirez J, Nájera MJ, Gutierrez-Gamarra E, Peralta R, Feliu J.

Future Sci OA. 2019 Feb 12;5(3):FSO375. doi: 10.4155/fsoa-2018-0122. eCollection 2019 Mar. No abstract available.

12.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Prado-Vázquez G, Gámez-Pozo A, Trilla-Fuertes L, Arevalillo JM, Zapater-Moros A, Ferrer-Gómez M, Díaz-Almirón M, López-Vacas R, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2019 Feb 7;9(1):1538. doi: 10.1038/s41598-018-38364-y.

13.

Stark effect or coverage dependence? Disentangling the EC-SEIRAS vibrational shift of sulfate on Au(111).

Pfisterer JHK, Zhumaev UE, Cheuquepan W, Feliu JM, Domke KF.

J Chem Phys. 2019 Jan 28;150(4):041709. doi: 10.1063/1.5047941.

PMID:
30709299
14.

Glycerol electrooxidation on Pd modified Au surfaces in alkaline media: Effect of the deposition method.

Mello GAB, Busó-Rogero C, Herrero E, Feliu JM.

J Chem Phys. 2019 Jan 28;150(4):041703. doi: 10.1063/1.5048489.

PMID:
30709262
15.

Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.

Cubillos-Zapata C, Balbás-García C, Avendaño-Ortiz J, Toledano V, Torres M, Almendros I, Casitas R, Zamarrón E, García-Sánchez A, Feliu J, Aguirre LA, Farre R, López-Collazo E, García-Rio F.

Respirology. 2019 Jul;24(7):684-692. doi: 10.1111/resp.13470. Epub 2019 Jan 17.

PMID:
30656807
16.

Determination of Specific Electrocatalytic Sites in the Oxidation of Small Molecules on Crystalline Metal Surfaces.

Farias MJS, Feliu JM.

Top Curr Chem (Cham). 2019 Jan 10;377(1):5. doi: 10.1007/s41061-018-0228-x. Review.

PMID:
30631969
17.

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018).

Gómez-España MA, Gallego J, González-Flores E, Maurel J, Páez D, Sastre J, Aparicio J, Benavides M, Feliu J, Vera R.

Clin Transl Oncol. 2019 Jan;21(1):46-54. doi: 10.1007/s12094-018-02002-w. Epub 2018 Dec 18.

18.

Effect of the Interfacial Water Structure on the Hydrogen Evolution Reaction on Pt(111) Modified with Different Nickel Hydroxide Coverages in Alkaline Media.

Sarabia FJ, Sebastián-Pascual P, Koper MTM, Climent V, Feliu JM.

ACS Appl Mater Interfaces. 2019 Jan 9;11(1):613-623. doi: 10.1021/acsami.8b15003. Epub 2018 Dec 27.

PMID:
30539624
19.

Versatile Electroanalytical Bioplatforms for Simultaneous Determination of Cancer-Related DNA 5-Methyl- and 5-Hydroxymethyl-Cytosines at Global and Gene-Specific Levels in Human Serum and Tissues.

Povedano E, Montiel VR, Valverde A, Navarro-Villoslada F, Yáñez-Sedeño P, Pedrero M, Montero-Calle A, Barderas R, Peláez-García A, Mendiola M, Hardisson D, Feliú J, Camps J, Rodríguez-Tomàs E, Joven J, Arenas M, Campuzano S, Pingarrón JM.

ACS Sens. 2019 Jan 25;4(1):227-234. doi: 10.1021/acssensors.8b01339. Epub 2018 Dec 14.

PMID:
30499292
20.

Citrate-Coated, Size-Tunable Octahedral Platinum Nanocrystals: A Novel Route for Advanced Electrocatalysts.

Moglianetti M, Solla-Gullón J, Donati P, Pedone D, Debellis D, Sibillano T, Brescia R, Giannini C, Montiel V, Feliu JM, Pompa PP.

ACS Appl Mater Interfaces. 2018 Dec 5;10(48):41608-41617. doi: 10.1021/acsami.8b11774. Epub 2018 Nov 20.

PMID:
30404443
21.

Can we avoid the toxicity of chemotherapy in elderly cancer patients?

Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ.

Crit Rev Oncol Hematol. 2018 Nov;131:16-23. doi: 10.1016/j.critrevonc.2018.08.008. Epub 2018 Aug 28. Review.

PMID:
30293701
22.

Comprehensive Study of the Enzymatic Catalysis of the Electrochemical Oxygen Reduction Reaction (ORR) by Immobilized Copper Efflux Oxidase (CueO) From Escherichia coli.

Chumillas S, Maestro B, Feliu JM, Climent V.

Front Chem. 2018 Aug 24;6:358. doi: 10.3389/fchem.2018.00358. eCollection 2018.

23.

Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes.

Mendiola M, Redondo A, Heredia-Soto V, Herranz J, Berjón A, Hernández A, Miguel-Martín M, Crespo R, Barriuso J, Cruz P, Yébenes L, Peláez-García A, Castelo B, DE Molina AR, Feliu J, Hardisson D.

Anticancer Res. 2018 Sep;38(9):5393-5400. doi: 10.21873/anticanres.12869.

PMID:
30194194
24.

ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone.

Aguirre-Portolés C, Feliu J, Reglero G, Ramírez de Molina A.

Mol Oncol. 2018 Oct;12(10):1735-1752. doi: 10.1002/1878-0261.12367. Epub 2018 Sep 17.

25.

Metals and metalloids in blood and feathers of common moorhens (Gallinula chloropus) from wetlands that receive treated wastewater.

López-Perea JJ, Laguna C, Jiménez-Moreno M, Rodríguez Martín-Doimeadios RC, Feliu J, Mateo R.

Sci Total Environ. 2019 Jan 1;646:84-92. doi: 10.1016/j.scitotenv.2018.07.265. Epub 2018 Jul 20.

PMID:
30048871
26.

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer.

Zapater-Moros A, Gámez-Pozo A, Prado-Vázquez G, Trilla-Fuertes L, Arevalillo JM, Díaz-Almirón M, Navarro H, Maín P, Feliú J, Zamora P, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jun 12;9(45):27586-27594. doi: 10.18632/oncotarget.25496. eCollection 2018 Jun 12.

27.

The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance.

Fernández LP, Sánchez-Martínez R, Vargas T, Herranz J, Martín-Hernández R, Mendiola M, Hardisson D, Reglero G, Feliu J, Redondo A, Ramírez de Molina A.

Sci Rep. 2018 May 31;8(1):8485. doi: 10.1038/s41598-018-26468-4.

28.

Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.

Alonso V, Escudero P, Fernández-Martos C, Salud A, Méndez M, Gallego J, Rodriguez JR, Martín-Richard M, Fernández-Plana J, Manzano H, Méndez JC, Zanui M, Falcó E, Gil-Raga M, Rojo F, Cuatrecasas M, Feliu J, García-Albéniz X, Maurel J.

Neoplasia. 2018 Jul;20(7):678-686. doi: 10.1016/j.neo.2018.05.004. Epub 2018 May 26.

29.

High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease.

Heredia-Soto V, Redondo A, Berjón A, Miguel-Martín M, Díaz E, Crespo R, Hernández A, Yébenes L, Gallego A, Feliu J, Hardisson D, Mendiola M.

Oncotarget. 2018 Apr 24;9(31):21893-21903. doi: 10.18632/oncotarget.25098. eCollection 2018 Apr 24.

30.

Perioperative transfusion management in gastric cancer surgery: Analysis of the Spanish subset of the EURECCA oesophago-gastric cancer registry.

Osorio J, Jericó C, Miranda C, Garsot E, Luna A, Miró M, Santamaría M, Artigau E, Rodríguez-Santiago J, Castro S, Feliu J, Aldeano A, Olona C, Momblan D, Ruiz D, Galofré G, Pros I, García-Albéniz X, Lozano M, Pera M.

Cir Esp. 2018 Nov;96(9):546-554. doi: 10.1016/j.ciresp.2018.03.010. English, Spanish.

PMID:
29773261
31.

Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia.

García-Muñoz R, Aguinaga L, Feliu J, Anton-Remirez J, Jorge-Del-Val L, Casajús-Navasal A, Nebot-Villacampa MJ, Daroca-Fernandez I, Domínguez-Garrido E, Rabasa P, Panizo C.

Immunotherapy. 2018 Mar 1;10(6):491-499. doi: 10.2217/imt-2017-0147.

PMID:
29562857
32.

Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis.

Koch C, Schwing AM, Herrmann E, Borner M, Diaz-Rubio E, Dotan E, Feliu J, Okita N, Souglakos J, Arkenau HT, Porschen R, Koopman M, Punt CJA, de Gramont A, Tournigand C, Zeuzem S, Trojan J.

Oncotarget. 2017 Dec 20;9(12):10272-10283. doi: 10.18632/oncotarget.23475. eCollection 2018 Feb 13.

33.

Molecular characterization of breast cancer cell response to metabolic drugs.

Trilla-Fuertes L, Gámez-Pozo A, Arevalillo JM, Díaz-Almirón M, Prado-Vázquez G, Zapater-Moros A, Navarro H, Aras-López R, Dapía I, López-Vacas R, Nanni P, Llorente-Armijo S, Arias P, Borobia AM, Maín P, Feliú J, Espinosa E, Fresno Vara JÁ.

Oncotarget. 2018 Jan 8;9(11):9645-9660. doi: 10.18632/oncotarget.24047. eCollection 2018 Feb 9.

34.

Pt-Richcore/Sn-Richsubsurface/Ptskin Nanocubes As Highly Active and Stable Electrocatalysts for the Ethanol Oxidation Reaction.

Rizo R, Arán-Ais RM, Padgett E, Muller DA, Lázaro MJ, Solla-Gullón J, Feliu JM, Pastor E, Abruña HD.

J Am Chem Soc. 2018 Mar 14;140(10):3791-3797. doi: 10.1021/jacs.8b00588. Epub 2018 Mar 2.

PMID:
29474073
35.

The transcriptional and mutational landscapes of lipid metabolism-related genes in colon cancer.

Fernández LP, Ramos-Ruiz R, Herranz J, Martín-Hernández R, Vargas T, Mendiola M, Guerra L, Reglero G, Feliu J, Ramírez de Molina A.

Oncotarget. 2017 Dec 21;9(5):5919-5930. doi: 10.18632/oncotarget.23592. eCollection 2018 Jan 19.

36.

Unraveling the Nature of Active Sites in Ethanol Electro-oxidation by Site-Specific Marking of a Pt Catalyst with Isotope-Labeled 13CO.

Farias MJS, Cheuquepán W, Tanaka AA, Feliu JM.

J Phys Chem Lett. 2018 Mar 15;9(6):1206-1210. doi: 10.1021/acs.jpclett.8b00030. Epub 2018 Feb 26.

PMID:
29451798
37.

Helping employees stay.

Feliu J.

Nurs Manage. 2018 Jan;49(1):7. doi: 10.1097/01.NUMA.0000527720.79961.4e. No abstract available.

PMID:
29287042
38.

Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain.

Molina-Garrido MJ, Guillén-Ponce C, Blanco R, Saldaña J, Feliú J, Antonio M, López-Mongil R, Ramos Cordero P, Gironés R; Working Group on Oncogeriatrics of the Spanish Society of Medical Oncology (SEOM).

J Geriatr Oncol. 2018 Jul;9(4):337-345. doi: 10.1016/j.jgo.2017.11.012. Epub 2017 Dec 13.

PMID:
29248435
39.

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martínez-Cardús A, Marín-Aguilera M, Horndler C, Martínez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martín-Richard M, Alonso V, Escudero P, Fernández-Martos C, Feliu J, Méndez JC, Méndez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, García-Albéniz X, Camps J, Maurel J.

Br J Cancer. 2017 Dec 5;117(12):1777-1786. doi: 10.1038/bjc.2017.279. Epub 2017 Nov 9.

40.

MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.

Gómez de Cedrón M, Acín Pérez R, Sánchez-Martínez R, Molina S, Herranz J, Feliu J, Reglero G, Enríquez JA, Ramírez de Molina A.

Mol Oncol. 2017 Dec;11(12):1768-1787. doi: 10.1002/1878-0261.12142. Epub 2017 Nov 6.

41.

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.

Ajani JA, Abramov M, Bondarenko I, Shparyk Y, Gorbunova V, Hontsa A, Otchenash N, Alsina M, Lazarev S, Feliu J, Elme A, Esko V, Abdalla K, Verma U, Benedetti F, Aoyama T, Mizuguchi H, Makris L, Rosati G; DIGEST Study Group.

Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275.

PMID:
28911091
42.

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Peláez-García A, Yébenes L, Berjón A, Angulo A, Zamora P, Sánchez-Méndez JI, Espinosa E, Redondo A, Heredia-Soto V, Mendiola M, Feliú J, Hardisson D.

PLoS One. 2017 Sep 8;12(9):e0183452. doi: 10.1371/journal.pone.0183452. eCollection 2017.

43.

Functional proteomics outlines the complexity of breast cancer molecular subtypes.

Gámez-Pozo A, Trilla-Fuertes L, Berges-Soria J, Selevsek N, López-Vacas R, Díaz-Almirón M, Nanni P, Arevalillo JM, Navarro H, Grossmann J, Gayá Moreno F, Gómez Rioja R, Prado-Vázquez G, Zapater-Moros A, Main P, Feliú J, Martínez Del Prado P, Zamora P, Ciruelos E, Espinosa E, Fresno Vara JÁ.

Sci Rep. 2017 Aug 30;7(1):10100. doi: 10.1038/s41598-017-10493-w.

44.

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases.

Aranda E, Aparicio J, Bilbao JI, García-Alfonso P, Maurel J, Rodríguez J, Sangro B, Vieitez JM, Feliu J.

Future Oncol. 2017 Oct;13(23):2065-2082. doi: 10.2217/fon-2017-0220. Epub 2017 Jul 13. Review.

PMID:
28703622
45.

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

Pineda E, Salud A, Vila-Navarro E, Safont MJ, Llorente B, Aparicio J, Vera R, Escudero P, Casado E, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Ayuso JR, Ripollés T, Bouzas R, Gironella M, García-Albéniz X, Feliu J, Maurel J.

Tumour Biol. 2017 Jun;39(6):1010428317705509. doi: 10.1177/1010428317705509.

46.

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.

Almhanna K, Wright D, Mercade TM, Van Laethem JL, Gracian AC, Guillen-Ponce C, Faris J, Lopez CM, Hubner RA, Bendell J, Bols A, Feliu J, Starling N, Enzinger P, Mahalingham D, Messersmith W, Yang H, Fasanmade A, Danaee H, Kalebic T.

Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19.

PMID:
28527133
47.

Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.

Valdés-Mora F, Locke WJ, Bandrés E, Gallego-Ortega D, Cejas P, García-Cabezas MA, Colino-Sanguino Y, Feliú J, Del Pulgar TG, Lacal JC.

Oncotarget. 2017 Apr 18;8(16):26755-26770. doi: 10.18632/oncotarget.15815.

48.

On the pH Dependence of the Potential of Maximum Entropy of Ir(111) Electrodes.

Ganassin A, Sebastián P, Climent V, Schuhmann W, Bandarenka AS, Feliu J.

Sci Rep. 2017 Apr 28;7(1):1246. doi: 10.1038/s41598-017-01295-1.

49.

Mobility and Oxidation of Adsorbed CO on Shape-Controlled Pt Nanoparticles in Acidic Medium.

Farias MJ, Busó-Rogero C, Vidal-Iglesias FJ, Solla-Gullón J, Camara GA, Feliu JM.

Langmuir. 2017 Jan 31;33(4):865-871. doi: 10.1021/acs.langmuir.6b03612. Epub 2017 Jan 20.

PMID:
28075603
50.

3'UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients.

Vargas T, Moreno-Rubio J, Herranz J, Cejas P, Molina S, Mendiola M, Burgos E, Custodio AB, De Miguel M, Martín-Hernández R, Reglero G, Feliu J, Ramírez de Molina A.

PLoS One. 2016 Dec 19;11(12):e0168423. doi: 10.1371/journal.pone.0168423. eCollection 2016.

Supplemental Content

Support Center